Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by Wino115on Apr 21, 2021 11:34am
88 Views
Post# 33037147

RE:RE:RE:Wino - Are you still planning

RE:RE:RE:Wino - Are you still planningYes, I agree. Most likely wanted to do an end-around and gauge your temperature and input. Obvioiusly, that should be important for Board composition, especially since most shareholders don't appear to vote.

SPCEO1 wrote: Excellant! Paul reached out to me yesterday to set up a meeting and I replied that it would be best to speak with you first. I trust your meeting will go really well and don't see any reason why it would not.

Wino115 wrote: Absolutely. I do believe the current Board permutation has the same limitations we've seen before that led to some of the longer-term issues we've all identified.  I will report back and push our points in a thoroughly professional and positively constructive manner.  Let's see what happens.

SPCEO1 wrote: to try to speak with Paul and Dawn? 

 




<< Previous
Bullboard Posts
Next >>